By 2023, marketers will no longer have access to third-party cookies on Google Chrome. The move aligns with the policy of Apple Safari and Mozilla Firefox, which have already blocked third-party cookies and left Chrome representing 92 percent of the remaining cookies on the internet. Many pharmaceutical brands have not invested solely in a cookie-based approach over the years, so those marketers were able to pursue additional marketing tactics on endemic and Point of Care channels to engage physicians during campaigns.
New research from Klick Applied Sciences found that people using interactive voice technology for information on medications still get the most accurate results from Google Assistant. Management says the data are especially relevant as consumers have increasingly been turning to these platforms during the pandemic.
New research from Klick Applied Sciences found that people using interactive voice technology for information on medications still get the most accurate results from Google Assistant. The data are especially relevant as consumers have increasingly been turning to these platforms during the pandemic.
In an effort to boost drug discovery for the “toughest drug discovery problems” through the use of machine learning, precision medicines company Relay Therapeutics is acquiring Waltham, Mass.-based ZebiAI with an $85 million upfront payment.
Studies have concluded that chatbots have the potential in treating mental health issues and could be used as an effective tool for delivering cognitive behavioral therapy.
Patient communications are no longer fit for purpose, and although Covid has brought this to the fore, the problems will continue for a long time after the vaccine roll-out if they are not resolved.
California announced an app to help people track their exposure to the coronavirus, becoming the largest U.S. state to take advantage of new technology from smartphone software makers Apple Inc. and Alphabet Inc.’s Google.
A new wave of mobile apps that help track exposure to the coronavirus is coming to U.S. states ahead of the holidays as public health officials bet that recently introduced features from Apple Inc. and Alphabet Inc.’s Google will significantly boost adoption and impact.
The U.S. Food and Drug Administration granted an emergency use authorization for a Covid-19 test from Alphabet Inc. unit Verily Life Sciences.
Alphabet Inc.’s Google and Apple Inc. announced a new system that will enable public health authorities to use smartphones to assist in contact tracing without having to build an app.